Ott1 (Rbm15) regulates thrombopoietin response in hematopoietic stem cells through alternative splicing of c-Mpl

Blood

Volumn 125, Issue 6, 2015, Pages 941-948

  Xiao, Nan ^a   Laha, Suparna ^a   Das, Shankar P ^a   Morlock, Kayla ^a   Jesneck, Jonathan L ^b   Raffel, Glen D ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Essess Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 3; HISTONE LYSINE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE; PROTEIN; PROTEIN C MPL; PROTEIN OTT1; PROTEIN SETD1B; RNA; RNA BINDING MOTIF PROTEIN 15; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR; UNCLASSIFIED DRUG; CHROMATIN; ISOPROTEIN; MESSENGER RNA; MPL PROTEIN, HUMAN; MPL PROTEIN, MOUSE; RBM15 PROTEIN, HUMAN; RBM15 PROTEIN, MOUSE; RNA BINDING PROTEIN;

ADULT; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; C MPL GENE; CELL PROLIFERATION; CHROMATIN; CONTROLLED STUDY; DEACETYLATION; ENZYME INHIBITION; EPIGENETICS; FEMALE; GENE; HEMATOPOIETIC STEM CELL; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPLICEOSOME; THROMBOCYTE; 3T3 CELL LINE; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOLOGY; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KNOCKOUT MOUSE; METABOLISM;

ALTERNATIVE SPLICING; ANIMALS; CELLS, CULTURED; CHROMATIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, KNOCKOUT; NIH 3T3 CELLS; PROTEIN ISOFORMS; RECEPTORS, THROMBOPOIETIN; RNA, MESSENGER; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; THROMBOPOIETIN;

EID: 84922384244     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-08-593392     Document Type: Article

References (43)

1. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest. 2005; 115(12): 3339-3347.
2. Ballmaier M, Germeshausen M, Schulze H, et al. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood. 2001; 97(1): 139-146.
3. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW. Thrombocytopenia in c-mpl-deficient mice. Science. 1994; 265(5177): 1445-1447.
4. Kimura S, Roberts AW, Metcalf D, Alexander WS. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci USA. 1998; 95(3): 1195-1200.
5. Yoshihara H, Arai F, Hosokawa K, et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell. 2007; 1(6): 685-697.
6. Qian H, Buza-Vidas N, Hyland CD, et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell. 2007; 1(6): 671-684.
7. Millot GA, Feger F, Garçon L, Vainchenker W, Dumenil D, Svinarchuk F. MplK, a natural variant of the thrombopoietin receptor with a truncated cytoplasmic domain, binds thrombopoietin but does not interfere with thrombopoietin-mediated cell growth. Exp Hematol. 2002; 30(2): 166-175.
8. Ma Z, Morris SW, Valentine V, et al. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet. 2001; 28(3): 220-221.
9. Mercher T, Coniat MB, Monni R, et al. Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc Natl Acad Sci USA. 2001; 98(10): 5776-5779.
10. Xiao N, Jani K, Morgan K, et al. Hematopoietic stem cells lacking Ott1 display aspects associated with aging and are unable to maintain quiescence during proliferative stress. Blood. 2012; 119(21): 4898-4907.
11. Ma X, Renda MJ, Wang L, et al. Rbm15 modulates Notch-induced transcriptional activation and affects myeloid differentiation. Mol Cell Biol. 2007; 27(8): 3056-3064.
12. Sawada T, Nishiyama C, Kishi T, et al. Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activity. J Biol Chem. 2008; 283(39): 26820-26828.
13. Lee JH, Skalnik DG. Rbm15-Mkl1 interacts with the Setd1b histone H3-Lys4 methyltransferase via a SPOC domain that is required for cytokine-independent proliferation. PLoS ONE. 2012; 7(8): e42965.
14. Zhou Z, Licklider LJ, Gygi SP, Reed R. Comprehensive proteomic analysis of the human spliceosome. Nature. 2002; 419(6903): 182-185.
15. Hiriart E, Gruffat H, Buisson M, et al. Interaction of the Epstein-Barr virus mRNA export factor EB2 with human Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links Spen proteins with splicing regulation and mRNA export. J Biol Chem. 2005; 280(44): 36935-36945.
16. Majerciak V, Uranishi H, Kruhlak M, et al. Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59. J Virol. 2011; 85(4): 1528-1540.
17. Raffel GD, Mercher T, Shigematsu H, et al. Ott1 (Rbm15) has pleiotropic roles in hematopoietic development. Proc Natl Acad Sci USA. 2007; 104(14): 6001-6006.
18. Raffel GD, Chu GC, Jesneck JL, et al. Ott1 (Rbm15) is essential for placental vascular branching morphogenesis and embryonic development of the heart and spleen. Mol Cell Biol. 2009; 29(2): 333-341.
19. Schulze H. Culture of murine megakaryocytes and platelets from fetal liver and bone marrow. Methods Mol Biol. 2012; 788: 193-203.
20. Mercher T, Raffel GD, Moore SA, et al. The OTTMAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model. J Clin Invest. 2009; 119(4): 852-864.
21. Mignotte V, Vigon I, Boucher de Crèvecoeur E, Roméo PH, Lemarchandel V, Chrétien S. Structure and transcription of the human c-mpl gene (MPL). Genomics. 1994; 20(1): 5-12.
22. Coers J, Ranft C, Skoda RC. A truncated isoform of c-Mpl with an essential C-terminal peptide targets the full-length receptor for degradation. J Biol Chem. 2004; 279(35): 36397-36404.
23. Pulikkan JA, Madera D, Xue L, et al. Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling. Blood. 2012; 120(4): 868-879.
24. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T. Epigenetics in alternative pre-mRNA splicing. Cell. 2011; 144(1): 16-26.
25. Kouraklis G, Theocharis S. Histone deacetylase inhibitors: a novel target of anticancer therapy (review). [review] Oncol Rep. 2006; 15(2): 489-494.
26. Cherblanc FL, Chapman KL, Reid J, et al. On the histone lysine methyltransferase activity of fungal metabolite chaetocin. J Med Chem. 2013; 56(21): 8616-8625.
27. Li J, Sabath DF, Kuter DJ. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets. Cytokine. 2000; 12(7): 835-844.
28. Smith EC, Teixeira AM, Chen RC, et al. Induction of megakaryocyte differentiation drives nuclear accumulation and transcriptional function of MKL1 via actin polymerization and RhoA activation. Blood. 2013; 121(7): 1094-1101.
29. Lannutti BJ, Epp A, Roy J, Chen J, Josephson NC. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis. Blood. 2009; 113(8): 1778-1785.
30. Wagner K, Kafert-Kasting S, Heil G, Ganser A, Eder M. Inhibition of granulocyte-macrophage colony-stimulating factor receptor function by a splice variant of the common beta-receptor subunit. Blood. 2001; 98(9): 2689-2696.
31. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 2001; 15(1): 43-58.
32. Vorlová S, Rocco G, Lefave CV, et al. Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation. Mol Cell. 2011; 43(6): 927-939.
33. Kornblihtt AR, Schor IE, Alló M, Dujardin G, Petrillo E, Muñoz MJ. Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat Rev Mol Cell Biol. 2013; 14(3): 153-165.
34. Li S, Guo W, Dewey CN, Greaser ML. Rbm20 regulates titin alternative splicing as a splicing repressor. Nucleic Acids Res. 2013; 41(4): 2659-2672.
35. Bechara EG, Sebestyén E, Bernardis I, Eyras E, Valcárcel J. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation. Mol Cell. 2013; 52(5): 720-733.
36. Choi ES, Hokom MM, Chen JL, et al. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis. Br J Haematol. 1996; 95(2): 227-233.
37. Niu C, Zhang J, Breslin P, Onciu M, Ma Z, Morris SW. c-Myc is a target of RNA-binding motif protein 15 in the regulation of adult hematopoietic stem cell and megakaryocyte development. Blood. 2009; 114(10): 2087-2096.
38. Steensma DP, Pardanani A, Stevenson WS, et al. More on Myb in myelofibrosis: molecular analyses of MYB and EP300 in 55 patients with myeloproliferative disorders. Blood. 2006; 107(4): 1733-1735; author reply 1735.
39. Nakada D, Oguro H, Levi BP, et al. Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy. Nature. 2014; 505(7484): 555-558.
40. Nishino T, Miyaji K, Ishiwata N, et al. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL. Exp Hematol. 2009; 37(11): 1364-1377; e1364.
41. Olnes MJ, Scheinberg P, Calvo KR, et al. Eltrombopag and improved hematopoiesis in refractory aplastic anemia. N Engl J Med. 2012; 367(1): 11-19.
42. O'Connor OA, Heaney ML, Schwartz L, et al. Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies. J Clin Oncol. 2006; 24(1): 166-173.
43. Bishton MJ, Harrison SJ, Martin BP, et al. Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopenia. Blood. 2011; 117(13): 3658-3668.